|The Society of Nuclear Medicine and Molecular Imaging (SNMMI) will have its annual meeting on June 11 – 15, 2016 at the San Diego Convention Center in San Diego, CA. This meeting provides attendees with a global perspective on the discipline of nuclear medicine and molecular imaging. This year, MILabs celebrates its 10th anniversary. At this occasion, we will highlight how MILabs latest innovations position you to go beyond the current limitations of PET/CT and SPECT/CT to improve translational research and patient care.|
We invite you to the visit MILabs’ Booth 1731, and attend our:
Read all about MILabs’ 10-years anniversary here:
New installations of MILabs Adaptive PET, SPECT and CT systems
|The universities of Oxford and Yale are joining the fast growing list of renowned institutions using MILabs molecular PET and SPECT imaging systems.|
The Oxford Institute for Radiation Oncology is the world’s largest and most comprehensive center for research in radiation oncology and biology. The new VECTor/CT system will mainly be used by Dr. Cornelissen to diagnose and treat pancreatic cancer. Read the press-release here.
At Yale University, Dr. Sinusas, Director of the Translational Research Imaging Center, will use the cardiac-gated high-resolution SPECT and CT modalities of their new system to develop innovative non-invasive imaging approaches for the assessment of myocardial viability, angiogenesis and infarction remodeling.
Other famous institutions and companies such as Clemson University and Genentech – a member of the Roche Group – have committed their X-ray CT imaging research to MILabs innovative Adaptive X-ray CT technology. Their wide range of research demands going from imaging diffusion of materials though vertically-positioned soil sample to high-resolution in vivo imaging of small animals underscores the unique flexibility and versatility of MILabs’ recently-released Adaptive CT system.
Customer in the spotlight: VUB
|Translational Nanobody research using In-vivo Cellular and Molecular Imaging (ICMI)|
Tony Lahoutte, PhD, MD is head of the Nuclear Medicine Department of the University Hospital Brussel and principal investigator at ICMI at the Vrije Universiteit Brussel, Belgium.
|At the In-Vivo Cellular and Molecular Imaging (ICMI) Lab of the Vrije Universiteit Brussel (VUB), several small animal imaging modalities are centralized, together with a unit for probe development and a vivarium for the housing of animals. The objective is a quick transition from translational research into clinical diagnostic practice. In this respect, the VECTor concurrent PET and SPECT imaging capability gives maximum flexibility. For instance, they can easily compare PET and SPECT tracers, one-on-one in vivo, and decide to change from a preclinical SPECT tracer to a PET tracer for clinical phase 1 trails if they need to. Read more…|
Ultra-High-Sensitivity SPECT for Ultra Low Dose Imaging
|MILabs is very honored that one of the users of its equipment, Oleksandra Ivashchenko, is a recipient of the JNM Alavi-Mandell Award for her publication entitled:|
“Ultra-High-Sensitivity Submillimeter Mouse SPECT”
J Nucl Med. 2015
Foundation for Fundamental Research and Matter (FOM) and MILabs start long term collaboration on clinical molecular imaging
|MILabs is accelerating its ongoing development of G-SPECT, strengthened by the commercial Innovation of the Year 2015 award from the World Molecular Imaging Society and with major aid from the important collaboration with the physics sections of the Dutch Science Foundation (NWO).|
|The company will focus on application-specific technical improvements and the ensuing economic health-care benefits that can be derived from using its innovative diagnostics imaging technology. Read more...|
|Meet us at upcoming conferences|
- SNNMI, June 11-15 ,2016, San Diego, Booth 1731
- WMIC, September 7-10, 2016, New York
- EANM, October 15-19, 2016, Barcelona